JPRN-UMIN000036854尚未招募未知
Verification of the impact on sequential therapy Of romosozumab according to the administration period of teriparatide - Verification of the impact on sequential therapy Of romosozumab according to the administration period of teriparatide
Shinshu University School of Medicine Dept. of Orthopaedic Surgery0 个研究点目标入组 90 人开始时间: 2019年5月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1:Patients who are allergic to romosozumab or teriparatide or eldecalcidol 2:Pregnant or breast-feeding patients 3:Patients considered to be at high risk of developing osteosarcoma 4:Patients with primary malignant or metastatic bone tumors 5:Patients with metabolic bone disease other than osteoporosis 6:Patients with unexplained high ALP 7:Others, patients judged by the research director as inappropriate 8:Hypocalcemia (serum corrected calcium level less than 8.0mg/dL) 9:Severe renal failure (less than eGFR15)
研究者
相似试验
招募中
不适用
Drug therapy of Helicobacter pylori infectioHelicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2017062234698N1Qazvin University of Medical Sciences120
进行中（未招募）
不适用
Efficacy and safety study of a sequential therapy of tocilizumab (TCZ) and, if initially inade-quately responded to tocilizumab (TCZ), followed by rituximab (RTX) in DMARD-IR patients with rheumatoid arthritis (MIRAI) - MIRAIEUCTR2010-022049-88-DERoche Pharma AG
已完成
3 期
A comparative study of sequential therapy and 10-day standard triple therapy for Helicobacter pylori infectioEradication of Helicobacter pylori infectionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Other infectious diseasesACTRN12613000377730Sanren Lin280
招募中
1 期
Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.MedDRA version: 20.0Level: PTClassification code: 10000614Term: Actinic keratosis Class: 100000004858Actinic keratosisCTIS2023-508091-11-00Clinica Universidad De Navarra40
已完成
2 期
Investigating the effect of Sequential Therapy and Triple Therapy for H-pylori treatmentIRCT20180131038581N2Bandare-abbas University of Medical Sciences144